Monitoring Minimal Residual Disease(MRD)in Pediatric B-acute Lymphoblastic Leukemia
Condition(s):B Acute Lymphoblastic LeukemiaLast Updated:July 27, 2021Recruiting
Hide Studies Not Open or Pending
Condition(s):B Acute Lymphoblastic LeukemiaLast Updated:July 27, 2021Recruiting
Condition(s):AmyloidosisLast Updated:September 10, 2021Completed
Condition(s):Multiple Myeloma; Minimal Residual DiseaseLast Updated:December 1, 2023Not yet recruiting
Condition(s):Pancreatic Cancer ResectableLast Updated:August 2, 2022Not yet recruiting
Condition(s):Minimal Residual Disease; Leukemia, Lymphoblastic, Acute; Leukemia, Myelogenous, AcuteLast Updated:October 26, 2021Terminated
Condition(s):B-cell Adult Acute Lymphoblastic Leukemia; Stem Cell Leukemia; Minimal Residual DiseaseLast Updated:February 21, 2022Terminated
Condition(s):NGS Monitor MRDLast Updated:October 15, 2019Unknown status
Condition(s):Multiple MyelomaLast Updated:January 29, 2024Recruiting
Condition(s):Acute Myeloid Leukemia (AML); Minimal Residual DiseaseLast Updated:February 20, 2019Withdrawn
Condition(s):Esophageal Carcinoma; Minimal Residual DiseaseLast Updated:July 19, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.